Page last updated: 2024-10-31

moclobemide and Pain

moclobemide has been researched along with Pain in 4 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research Excerpts

ExcerptRelevanceReference
"This trial aimed to study moclobemide, a reversible, Type-A selective monoamine oxidase inhibitor, in patients with chronic neuropathic pain."9.08Moclobemide in chronic neuropathic pain: preliminary case reports. ( Busch, AF; Fawcett, JP; Jones, D; Menkes, DB, 1995)
"This trial aimed to study moclobemide, a reversible, Type-A selective monoamine oxidase inhibitor, in patients with chronic neuropathic pain."5.08Moclobemide in chronic neuropathic pain: preliminary case reports. ( Busch, AF; Fawcett, JP; Jones, D; Menkes, DB, 1995)
" The efficacies between the two dosing regimens as determined by the HAM-D score and from the CGI were found not to differ significantly."2.68A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R) ( Caracatsanis, A; Collier, J; Collins, C; Cramer, D; Edwards, R; Fox, K; Newburn, G; Reeves, J; Thomas, H, 1995)
" While clinical aspects will be presented in a subsequent review, this article focuses primarily on moclobemide's evolution, pharmacodynamic and pharmacokinetic properties."2.41Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties. ( Bonnet, U, 2002)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonnet, U1
Menkes, DB1
Fawcett, JP1
Busch, AF1
Jones, D1
Newburn, G1
Edwards, R1
Thomas, H1
Collier, J1
Fox, K1
Collins, C1
Cramer, D1
Reeves, J1
Caracatsanis, A1
Coquoz, D1
Porchet, HC1
Dayer, P1

Reviews

1 review available for moclobemide and Pain

ArticleYear
Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties.
    CNS drug reviews, 2002,Fall, Volume: 8, Issue:3

    Topics: Animals; Antidepressive Agents; Anxiety; Cognition Disorders; Depression; Disease Models, Animal; Dr

2002

Trials

3 trials available for moclobemide and Pain

ArticleYear
Moclobemide in chronic neuropathic pain: preliminary case reports.
    The Clinical journal of pain, 1995, Volume: 11, Issue:2

    Topics: Adult; Aged; Analgesics; Benzamides; Chronic Disease; Female; Humans; Male; Middle Aged; Moclobemide

1995
A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R)
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:4 Suppl 2

    Topics: Adult; Antidepressive Agents; Anxiety; Benzamides; Depressive Disorder; Double-Blind Method; Female;

1995
[Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide].
    Schweizerische medizinische Wochenschrift, 1991, Dec-07, Volume: 121, Issue:49

    Topics: Analgesics; Antidepressive Agents; Benzamides; Desipramine; Double-Blind Method; Electric Stimulatio

1991